Literature DB >> 14661862

Differential effects of typical and atypical neuroleptics on mitochondrial function in vitro.

Josephine S Modica-Napolitano1, Christopher J Lagace, William A Brennan, June R Aprille.   

Abstract

A series of typical (chlorpromazine, haloperidol and thioridazine) and atypical (risperidone, quetiapine, clozapine and olanzapine) antipsychotics were tested for effects on integrated bioenergetic functions of isolated rat liver mitochondria. Polarographic measurement of oxygen consumption in freshly isolated mitochondria showed that electron transfer activity at respiratory complex I is inhibited by chlorpromazine, haloperidol, risperidone, and quetiapine, but not by clozapine, olanzapine, or thioridazine. Chlorpromazine and thioridazine act as modest uncouplers of oxidative phosphorylation. The typical neuroleptics inhibited NADH-coenzyme Q reductase in freeze-thawed mitochondria, which is a direct measure of complex I enzyme activity. The inhibition of NADH-coenzyme Q reductase activity by the atypicals risperidone and quetiapine was 2-4 fold less than that for the typical neuroleptics. Clozapine and olanzapine had only slight effects on NADH-coenzyme Q reductase activity, even at 200 microM. The relative potencies of these neuroleptic drugs as inhibitors of mitochondrial bioenergetic function is similar to their relative potencies as risk factors in the reported incidence of extrapyramidal symptoms, including tardive dyskinesia (TD). This suggests that compromised bioenergetic function may be involved in the cellular pathology underlying TD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14661862     DOI: 10.1007/bf02980205

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  24 in total

1.  Gene networks and haloperidol-induced catalepsy.

Authors:  O D Iancu; P Darakjian; B Malmanger; N A R Walter; S McWeeney; R Hitzemann
Journal:  Genes Brain Behav       Date:  2011-11-11       Impact factor: 3.449

Review 2.  Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.

Authors:  Jeffrey A Lieberman; Frank P Bymaster; Herbert Y Meltzer; Ariel Y Deutch; Gary E Duncan; Christine E Marx; June R Aprille; Donard S Dwyer; Xin-Min Li; Sahebarao P Mahadik; Ronald S Duman; Joseph H Porter; Josephine S Modica-Napolitano; Samuel S Newton; John G Csernansky
Journal:  Pharmacol Rev       Date:  2008-09       Impact factor: 25.468

3.  Exploring mechanisms of increased cardiovascular disease risk with antipsychotic medications: Risperidone alters the cardiac proteomic signature in mice.

Authors:  Megan Beauchemin; Ramaz Geguchadze; Anyonya R Guntur; Kathleen Nevola; Phuong T Le; Deborah Barlow; Megan Rue; Calvin P H Vary; Christine W Lary; Katherine J Motyl; Karen L Houseknecht
Journal:  Pharmacol Res       Date:  2019-12-23       Impact factor: 7.658

4.  Systems Analysis of the 22q11.2 Microdeletion Syndrome Converges on a Mitochondrial Interactome Necessary for Synapse Function and Behavior.

Authors:  Avanti Gokhale; Cortnie Hartwig; Amanda A H Freeman; Julia L Bassell; Stephanie A Zlatic; Christie Sapp Savas; Trishna Vadlamudi; Farida Abudulai; Tyler T Pham; Amanda Crocker; Erica Werner; Zhexing Wen; Gabriela M Repetto; Joseph A Gogos; Steven M Claypool; Jennifer K Forsyth; Carrie E Bearden; Jill Glausier; David A Lewis; Nicholas T Seyfried; Jennifer Q Kwong; Victor Faundez
Journal:  J Neurosci       Date:  2019-03-04       Impact factor: 6.167

5.  Psychotropic medications and mitochondrial toxicity.

Authors:  Rebecca Anglin; Patricia Rosebush; Michael Mazurek
Journal:  Nat Rev Neurosci       Date:  2012-07-25       Impact factor: 34.870

6.  Mitochondrial dysfunction as a neurobiological subtype of autism spectrum disorder: evidence from brain imaging.

Authors:  Suzanne Goh; Zhengchao Dong; Yudong Zhang; Salvatore DiMauro; Bradley S Peterson
Journal:  JAMA Psychiatry       Date:  2014-06       Impact factor: 21.596

7.  Mitochondrial Complex I Deficiency in Schizophrenia and Bipolar Disorder and Medication Influence.

Authors:  Brandi L Rollins; Ling Morgan; Brooke E Hjelm; Adolfo Sequeira; Alan F Schatzberg; Jack D Barchas; Francis S Lee; Rick M Myers; Stanley J Watson; Huda Akil; Steven G Potkin; William E Bunney; Marquis P Vawter
Journal:  Mol Neuropsychiatry       Date:  2017-11-30

8.  Assessment of drug-induced mitochondrial dysfunction via altered cellular respiration and acidification measured in a 96-well platform.

Authors:  Sashi Nadanaciva; Payal Rana; Gyda C Beeson; Denise Chen; David A Ferrick; Craig C Beeson; Yvonne Will
Journal:  J Bioenerg Biomembr       Date:  2012-06-12       Impact factor: 2.945

Review 9.  Psychiatric drugs impact mitochondrial function in brain and other tissues.

Authors:  Shawna T Chan; Michael J McCarthy; Marquis P Vawter
Journal:  Schizophr Res       Date:  2019-11-16       Impact factor: 4.939

10.  Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects.

Authors:  Kwang H Choi; Brandon W Higgs; Serge Weis; Jonathan Song; Ida C Llenos; Jeannette R Dulay; Robert H Yolken; Maree J Webster
Journal:  BMC Psychiatry       Date:  2009-09-16       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.